What Your Estradiol Level Reveals About Your Fertility
Part 5 of the SwimScore Hormone Series
Estradiol is the hormone that surprises most men when it appears on their results. It's oestrogen, the hormone associated with female biology, and seeing it on a male fertility panel can feel confusing. But men produce oestrogen throughout their lives, and it plays a genuine role in sperm production, bone health, libido, and the balance of the broader hormonal system. Both too much and too little appear to cause problems. And the relationship between estradiol and testosterone, not just the estradiol level alone, is where the most clinically meaningful data sits.
This article explains what estradiol actually does in men, what your result tells you, where the research is strong, and where it is genuinely uncertain. Estradiol is the most contested hormone in this series, and we'll present it as such.
What Estradiol Is and How Men Produce It
Estradiol is the most potent form of oestrogen. In men, most of it isn't produced directly. It's converted from testosterone by an enzyme called aromatase, which is found in adipose tissue (body fat), the liver, the brain, and to a lesser extent the testes and adrenal glands. This conversion process is called aromatization. The more testosterone you have available and the more aromatase activity you have, the more estradiol your body produces as a byproduct.
In small amounts, estradiol is necessary. It supports bone density, plays a role in brain function and mood, contributes to libido, and is involved in the normal development of sperm. Estradiol receptors have been found on Leydig cells, Sertoli cells, and developing germ cells in the testes, which tells us the hormone has direct effects on sperm production, not just systemic effects on the body. (NCBI, 2023)
The problem arises at the extremes. Too much estradiol suppresses the hormonal system that drives testosterone and sperm production. Too little disrupts the estrogen signalling that developing sperm appear to need. The right level is a balance, and that balance is partly determined by the ratio between testosterone and estradiol rather than by either number in isolation.
What the Normal Range Means
The reference range for estradiol in adult men is approximately 10 to 40 pg/mL on standard assays, though this varies between laboratories and testing methods. Some clinicians use a narrower optimal range of 20 to 30 pg/mL for men focused on hormonal health. The Male Infertility Guide uses 59 pg/mL as the upper threshold for clinical concern, while some researchers use 50 pg/mL. There is no universal consensus on the precise cutoffs.
This variability in thresholds is itself informative. Estradiol measurement in men is technically tricky. Standard immunoassay tests, which are used in most routine blood panels, were designed for women and are less accurate at the lower concentrations typical of men. The ultrasensitive liquid chromatography mass spectrometry assay, commonly called LC/MS, is more accurate for male estradiol testing but less widely used in routine clinical practice. The number on a standard test should be interpreted with that limitation in mind.
Within the normal range, with a normal testosterone and normal semen parameters, estradiol is doing its job without disrupting the hormonal system.
What High Estradiol Means
Elevated estradiol in men, particularly above 50 to 59 pg/mL alongside low or low-normal testosterone, is the pattern most associated with hormonal disruption relevant to fertility.
The mechanism is the same one covered in the LH and testosterone articles in this series. High estradiol feeds back negatively to the hypothalamus and pituitary, suppressing the production of GnRH, which reduces FSH and LH, which reduces testosterone production and sperm development. High estradiol doesn't just reflect a hormonal imbalance. It actively perpetuates one by suppressing the signals needed to correct it. (Translational Andrology and Urology, 2013)
The most common cause of elevated estradiol in men is excess body fat, particularly abdominal fat. Fat tissue contains high concentrations of aromatase, so the more fat a man carries, the more testosterone gets converted to estradiol. As estradiol rises, it suppresses LH, which reduces testosterone, which can paradoxically cause further fat gain as testosterone's protective effect on body composition weakens. This is a cycle that starts with adipose tissue and compounds itself hormonally over time.
Other causes of elevated estradiol include liver dysfunction (the liver metabolises estradiol, so impaired liver function allows it to accumulate), certain medications, and in rare cases oestrogen-secreting tumours.
The clinical picture of significantly elevated estradiol in men can include reduced libido, erectile dysfunction, gynecomastia, and impaired semen parameters. Some men have no obvious symptoms despite elevated levels, which is why testing matters.
The aromatase inhibitor data is where the intervention evidence sits. Aromatase inhibitors are medications that block the enzyme converting testosterone to estradiol, raising testosterone while reducing estradiol. In men with a low testosterone-to-estradiol ratio, typically below 10:1, aromatase inhibitor treatment has shown improvements in semen parameters in several studies. One trial using anastrozole in subfertile men with abnormal testosterone-to-estradiol ratios showed significant increases in sperm concentration, total sperm count, progressive motility, and total progressive motile count, with an 86% response rate in the treated group. (Translational Andrology and Urology, 2022) A 2025 large cohort analysis confirmed that lower testosterone-to-estradiol ratios were associated with worse semen parameters in both fertile and subfertile men. (Urology, 2025)
The AUA and Endocrine Society guidelines note that the evidence for aromatase inhibitors in male infertility is promising but not yet sufficient for routine recommendation. These are prescription medications requiring clinical management and careful monitoring, not a supplement protocol.
What Low Estradiol Means
This is where the estradiol story gets genuinely complicated, and where we think the field is less settled than the elevated estradiol conversation suggests.
Some research indicates that low estradiol is also associated with impaired spermatogenesis. A study of 360 men at an infertility clinic found that azoospermic and oligozoospermic patients had significantly lower estradiol levels than fertile controls, not higher. (PubMed, 1995) A study of 451 infertile men similarly found that subfertile men had lower mean estradiol than fertile men. (Fertility and Sterility, 1988) Mouse models in which the aromatase gene is knocked out, eliminating estradiol production entirely, showed significant impairment of spermatogenesis and reduced fertility. (Urología Colombiana, 2024)
The interpretation is that estradiol at appropriate levels supports sperm development through direct effects on testicular cells, and that too little disrupts that process. This is not the same as saying high estradiol is good. It means the relationship is U-shaped: both extremes impair spermatogenesis, and the optimal zone is somewhere in the middle.
The honest caveat: the older clinical study by Fahmy et al. measured estradiol in 451 infertile men and concluded that estradiol measurements in male patients are not useful in clinical infertility practice, because although mean levels differed from fertile men, there was no prognostic value for individual patients and no relationship to specific infertility diagnoses. (Fertility and Sterility, 1988) That finding has not been fully overturned. More recent data on aromatase inhibitors and testosterone-to-estradiol ratios has generated renewed interest in estradiol as a clinically useful marker, but the individual predictive value of an estradiol result in isolation remains limited.
The Testosterone-to-Estradiol Ratio
The most clinically useful framing for estradiol in male fertility is not the absolute level but the ratio to testosterone. A testosterone-to-estradiol ratio below 10:1 is the threshold most commonly cited in the clinical literature for considering aromatase inhibitor treatment. This ratio captures something the individual numbers cannot: the balance between androgenic drive and oestrogenic suppression in the hormonal system.
A man with a testosterone of 400 ng/dL and estradiol of 50 pg/mL has a ratio of 8:1, which many clinicians would consider treatment-relevant. A man with a testosterone of 800 ng/dL and estradiol of 50 pg/mL has a ratio of 16:1, where the elevated estradiol is less likely to be clinically significant because testosterone is still dominant in the balance.
This is why estradiol should never be read without testosterone alongside it. The absolute estradiol number tells you part of the story. The ratio tells you whether the hormonal balance is working.
Reading Estradiol Alongside Other Markers
High estradiol with low testosterone and low LH is the pattern most consistent with aromatase excess, typically driven by obesity. The hormonal system is being suppressed from above by excess oestrogenic signalling.
High estradiol with high testosterone can occur in men on TRT or using anabolic steroids, where large amounts of exogenous testosterone are being aromatized into estradiol. This is why estradiol monitoring is part of responsible testosterone therapy management.
Low estradiol with low testosterone in a man with primary testicular failure reflects reduced testosterone available for aromatization, so both testosterone and estradiol fall together. The low estradiol is a consequence, not a separate problem.
Normal estradiol with poor semen parameters and normal testosterone: estradiol is probably not the driver. Look at other parameters, DNA fragmentation, and lifestyle factors.
What Can Be Done
For elevated estradiol driven by obesity, the primary intervention is fat loss. Reducing adipose tissue reduces aromatase activity, which reduces estradiol conversion, which allows testosterone to rise and the HPG axis suppression to ease. This is the most sustainable and evidence-based approach for obesity-driven hormonal imbalance.
For men with a confirmed low testosterone-to-estradiol ratio alongside poor semen parameters and normal or low testosterone, aromatase inhibitors are the clinical intervention with the most supporting data. Anastrozole and letrozole are the most commonly used. These are prescription medications requiring a clinician to prescribe, monitor hormone levels, and assess semen parameters over time. The routine use of aromatase inhibitors without confirmed ratio abnormality is not supported by current guidelines.
There is no supplement with meaningful clinical evidence for reducing estradiol in men with genuine hyperestrogenism. Compounds like DIM (diindolylmethane) and zinc are sometimes marketed for this purpose. The evidence for DIM specifically lowering estradiol to clinically meaningful degrees in men with elevated levels is weak. Zinc has a modest supportive role in testosterone synthesis but does not directly address aromatase activity. We would not recommend a supplement protocol as a substitute for clinical management when estradiol is genuinely and persistently elevated.
Our Take
Estradiol is the most nuanced and contested hormone in this series. Both elevated and low levels have been associated with impaired spermatogenesis, though the elevated estradiol story is better supported by intervention data. The testosterone-to-estradiol ratio is more clinically informative than either number in isolation. And an older but methodologically sound study concluded that individual estradiol measurements offer no prognostic value in male infertility, a finding the field has not fully moved past despite more recent interest in aromatase inhibition.
What we know: estradiol is a real participant in the hormonal system governing sperm production, not just a bystander. The testosterone-to-estradiol ratio matters, particularly in men with obesity, low testosterone, and poor semen parameters. Aromatase inhibitors show meaningful semen parameter improvements in men with confirmed ratio abnormality, though they are not yet routine clinical recommendations.
What we don't know: the precise threshold at which estradiol becomes clinically significant for fertility in individual men. Whether measuring estradiol in routine male fertility panels provides meaningful additional predictive value beyond testosterone, LH, and FSH alone. Whether the low estradiol association with impaired spermatogenesis is causal or a reflection of reduced testosterone available for aromatization.
The practical takeaway: if your estradiol is elevated, look at it alongside your testosterone ratio. If you carry significant body fat and have low testosterone with elevated estradiol, the route forward starts with body composition, not medication. If the ratio is confirmed as abnormal by a clinician and other causes have been addressed, aromatase inhibitor treatment has meaningful evidence behind it. If your estradiol is within normal range, it is unlikely to be the primary driver of any semen parameter problems you're seeing.
This is Part 5 of the SwimScore Hormone Series. Next up: Thyroid hormones, how an underactive or overactive thyroid disrupts sperm production in ways that are frequently missed in standard male fertility workups.
See here links to the earlier hormone articles on LH, FSH, testosterone, and prolactin.
SwimScore uses CLIA-certified labs for all semen analysis and hormone testing, assessed against WHO 6th Edition clinical thresholds.
